Healthcare and Life Sciences Webinar Series

November 2020 - April 2021

Register

COMPLIMENTARY WEBINAR SERIES

Join McGuireWoods partners as we discuss recent developments in healthcare and life sciences legal space in this multi-part webinar series. Below are several topics we will cover over the course of the series. For replay of previous webinars, click here


Watch for additional information about future webinars in this series:

Labor and Employment Trends and Hot Button Issues
Thursday, February 25, 2021

What to Do When the Government Comes Knocking
Thursday, March 18, 2021

Recent Developments and Trending Areas in ANDA Litigation
Thursday, April 22, 2021

Login details will be sent to registrants before each webinar.


Previous Sessions

Recent Developments in False Claims Act Litigation
Thursday, November 19, 2020
Featuring McGuireWoods partner David J. Pivnick and attorney Brett W. Barnett
Reviews recent developments in FCA litigation, along with recent trends and developments in the DOJ’s areas of focus.

Recent Developments in Managed Care Litigation
Thursday, December 10, 2020
Featuring McGuireWoods partners Edwin E. Brooks and Steven D. Hamilton and attorney Kathryn A. Campbell
Discusses recent developments in managed care litigation, providing insight and strategy on defending and prosecuting managed care claims.

COVID-19 Impacts on Healthcare Deal Diligence and Structuring — Regulatory, Transactional and Financial
Thursday, January 21, 2021
Featuring McGuireWoods attorneys Timothy J. Fry and Amanda K. Roenius, and RSM's Patrick Landry and Matt Wolf 
This webinar focuses on various regulatory, transactional and financial considerations for deal diligence in healthcare transactions in light of the COVID-19 pandemic. Discusses changes to diligence review related to financial valuations, employees, government stimulus funds and healthcare matters, such as telehealth compliance.


Our programs are intended for the benefit of our clients and contacts and we reserve the right to refuse any registration at our sole discretion.
Back to top